Cover Image
市場調查報告書

Laila Pharmaceuticals Pvt. Ltd.:產品平台分析

Laila Pharmaceuticals Pvt. Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 318937
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
Laila Pharmaceuticals Pvt. Ltd.:產品平台分析 Laila Pharmaceuticals Pvt. Ltd. - Product Pipeline Review - 2014
出版日期: 2014年11月14日 內容資訊: 英文 29 Pages
簡介

Laila Pharmaceuticals Pvt. Ltd.是製造及銷售從植物醫藥到藥物遞送製劑與新治療藥的藥物研發公司。該公司活用最新的分子生物學以求物遞送及新藥研發,提供植物抽取物,植物化學物質,標記化合物。該公司產品廣泛應用於眼科疾病,神經退化性疾病,腸胃障礙,皮膚疾病,代謝性障礙,傳染病等治療上。

本報告提供Laila Pharmaceuticals Pvt. Ltd.的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,以及最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Laila Pharmaceuticals Pvt. Ltd.的基本資料

  • Laila Pharmaceuticals Pvt. Ltd.概要
  • 主要資訊
  • 企業資料

Laila Pharmaceuticals Pvt. Ltd.:R&D概要

  • 主要的治療範圍

Laila Pharmaceuticals Pvt. Ltd.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Laila Pharmaceuticals Pvt. Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Laila Pharmaceuticals Pvt. Ltd.:藥物簡介

  • LP-00209
  • LP-00409
  • LP-01309
  • LP-00109
  • Drugs for Alzheimer's Disease
  • Drug for Diabetes
  • Drug for HIV
  • LP-00509

Laila Pharmaceuticals Pvt. Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Laila Pharmaceuticals Pvt. Ltd.:暫停中的計劃

Laila Pharmaceuticals Pvt. Ltd.:總公司和子公司的所在地

附錄

圖表

目錄
Product Code: GMDHC06459CDB

Summary

Global Markets Direct's, 'Laila Pharmaceuticals Pvt. Ltd. - Product Pipeline Review - 2014', provides an overview of the Laila Pharmaceuticals Pvt. Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Laila Pharmaceuticals Pvt. Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Laila Pharmaceuticals Pvt. Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Laila Pharmaceuticals Pvt. Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Laila Pharmaceuticals Pvt. Ltd.'s pipeline products

Reasons to buy

  • Evaluate Laila Pharmaceuticals Pvt. Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Laila Pharmaceuticals Pvt. Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Laila Pharmaceuticals Pvt. Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Laila Pharmaceuticals Pvt. Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laila Pharmaceuticals Pvt. Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Laila Pharmaceuticals Pvt. Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Laila Pharmaceuticals Pvt. Ltd. Snapshot
    • Laila Pharmaceuticals Pvt. Ltd. Overview
    • Key Information
    • Key Facts
  • Laila Pharmaceuticals Pvt. Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products Glance
    • Laila Pharmaceuticals Pvt. Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Laila Pharmaceuticals Pvt. Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Laila Pharmaceuticals Pvt. Ltd. - Drug Profiles
    • LP-00209
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LP-00409
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LP-01309
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LP-00109
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drugs for Alzheimer's Disease
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for Diabetes
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Drug for HIV
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • LP-00509
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Analysis
    • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products by Target
    • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products by Route of Administration
    • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products by Molecule Type
    • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products by Mechanism of Action
  • Laila Pharmaceuticals Pvt. Ltd. - Dormant Projects
  • Laila Pharmaceuticals Pvt. Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Laila Pharmaceuticals Pvt. Ltd., Key Information
  • Laila Pharmaceuticals Pvt. Ltd., Key Facts
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Indication, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Stage of Development, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Monotherapy Products in Pipeline, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Phase II, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Phase I, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Preclinical, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Discovery, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Target, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Route of Administration, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Molecule Type, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Dormant Developmental Projects,2014
  • Laila Pharmaceuticals Pvt. Ltd., Other Locations

List of Figures

  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Top 10 Indication, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Stage of Development, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Monotherapy Products in Pipeline, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Top 10 Target, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • Laila Pharmaceuticals Pvt. Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top